Genetic polymorphisms impose vital impact on malignant tumors, but neither Hogewind's research25 nor current study revealed that FKBP4 polymorphisms was correlated with breast cancer risk, therefore further researches should be carried out to figure out the prognostic role of FKBP4 polymorphisms in BC patients. The gene discussed is FKBP4; the disease is breast carcinoma.